JFG
AXSM icon

Jefferies Financial Group’s Axsome Therapeutics AXSM Stock Holding History

Jefferies Financial Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.62M Buy
+15,500
New +$2.68M 0.03% 522
2025
Q3 		– Sell
-2,500
Closed -$261K – 1457
2025
Q2 		$261K Buy
+2,500
New +$265K ﹤0.01% 1066
2025
Q1 		– Sell
-40,700
Closed -$3.44M – 1623
2024
Q4 		$3.44M Buy
+40,700
New +$3.74M 0.04% 484
2024
Q3 		– Sell
-15,859
Closed -$1.28M – 1439
2024
Q2 		$1.28M Sell
15,859
-316,907
-95% -$23.5M 0.03% 671
2024
Q1 		$26.6M Sell
332,766
-230,569
-41% -$19.4M 0.54% 66
2023
Q4 		$44.8M Buy
563,335
+10,140
+2% +$678K 0.7% 47
2023
Q3 		$38.7M Buy
+553,195
New +$41.4M 0.96% 39

Other funds holding AXSM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return